Flubrotizolam presents itself as a synthetic benzodiazepine derivative. Introduced for medical purposes, flubrotizolam possesses intense anxiolytic effects. Its structural properties reveal a high affinity for the GABA receptor, producing significant CNS depression. Despite its potential pharmaceutical applications, flubrotizolam's unregulated use